Recombinant Rat Insulin-like growth factor 1 receptor (Igf1r)

What is Insulin-like Growth Factor 1 Receptor (IGF1R) in rats?

Rat Insulin-like Growth Factor 1 Receptor (IGF1R), also known as CD221, IGF1-R, IGFIR, or JTK13, is a transmembrane receptor tyrosine kinase that binds to insulin-like growth factor 1 (IGF-1) and mediates its biological effects. The rat IGF1R protein (UniProt: P24062) functions as a critical regulator of cell growth, differentiation, and survival across multiple tissue types . The receptor consists of extracellular alpha subunits containing the ligand-binding domain and transmembrane beta subunits with tyrosine kinase activity. Upon binding of IGF-1, the receptor undergoes autophosphorylation, initiating downstream signaling cascades that regulate numerous cellular processes. Dysregulation of IGF1R signaling has been implicated in various pathological conditions including cancer, diabetes, and neurodegenerative disorders .

How does IGF1R expression differ across rat tissues?

IGF1R is widely expressed in rat tissues, with varying levels depending on developmental stage, physiological status, and tissue type. In rat cardiomyocytes, IGF1R mediates crucial growth and survival signals through activation of multiple pathways including JAK/STAT signaling . In renal tissues, IGF1R plays important roles in regulating glomerular filtration rate (GFR) and renal plasma flow (RPF), particularly through effects on glomerular ultrafiltration coefficient (LpA) and efferent arteriolar resistance (RE) . The expression of IGF1R is particularly prominent during developmental stages and can be modulated by physiological conditions such as starvation. In food-deprived rats, the downstream effects of IGF1R activation can differ compared to well-fed animals, with IGF-1 administration capable of reversing some of the glomerular hemodynamic effects induced by short-term food deprivation .

What are the primary signaling pathways activated by IGF1R in rat models?

IGF1R activates multiple signaling pathways in rat tissues:

• JAK/STAT Pathway: In rat cardiomyocytes, IGF-1 binding to IGF1R activates JAK1 (but not JAK2 or Tyk2) as early as 2 minutes post-stimulation, with phosphorylation peaking at 5 minutes . This leads to both tyrosine and serine phosphorylation of STAT1 and STAT3. Interestingly, the phosphorylation patterns differ between these STAT proteins, with STAT1 phosphorylation peaking at 15 minutes (correlating with JAK1 activation), while STAT3 phosphorylation is sustained for up to 120 minutes .

• MAPK and PI3K Pathways: IGF1R activates these canonical pathways in various rat tissues, although experiments with PD98058 (MAPK inhibitor) and wortmannin (PI3K inhibitor) have shown they may not be essential for certain downstream effects, such as STAT3 tyrosine phosphorylation in cardiomyocytes .

• Calcium-dependent signaling: Research indicates that calcium signaling is important for IGF1R function, as demonstrated by the significant attenuation of STAT3 tyrosine phosphorylation by BAPTA-AM (calcium chelator) and chelerythrine (PKC inhibitor) .

How does IGF1R signaling affect renal function in rat models?

IGF1R signaling has profound effects on rat renal function through specific glomerular hemodynamic mechanisms. Administration of recombinant human insulin-like growth factor I (rhIGF-I) increases GFR and renal plasma flow (RPF) in both starved and non-starved rats . Detailed micropuncture studies have revealed the precise mechanisms:

• IGF1R activation increases single nephron glomerular filtration rate (SNGFR), single nephron blood flow rate (SNBF), and single nephron plasma flow rate (SNPF) .

• The increase in filtration and flow rates is primarily attributable to:

  • An increase in glomerular ultrafiltration coefficient (LpA) to approximately twice the control values

  • A decrease in efferent arteriolar resistance (RE)

  • A possible but not statistically significant decrease in afferent arteriolar resistance (RA)

• In food-deprived rats, IGF1R stimulation can reverse starvation-induced reductions in glomerular function. Control starved rats typically show lower SNGFR, SNBF, and SNPF compared to non-starved rats, resulting from:

  • Reduced SNPF

  • Lower glomerular transcapillary hydrostatic pressure difference (delta P)

  • Possibly reduced LpA

  • Tendency toward higher RA and RE

These findings demonstrate that IGF1R signaling has important compensatory roles in maintaining renal function during physiological stress conditions such as starvation.

What mechanisms regulate IGF1R-mediated JAK/STAT signaling in rat cardiomyocytes?

The regulation of IGF1R-mediated JAK/STAT signaling in rat cardiomyocytes involves complex mechanisms with differential activation patterns and regulatory influences:

• Selective JAK activation: IGF-1 stimulation specifically activates JAK1 but not JAK2 or Tyk2 in primary cultured neonatal rat cardiomyocytes .

• Differential STAT activation kinetics: Following IGF-1 stimulation (10^-8 mol/L), both STAT1 and STAT3 undergo tyrosine and serine phosphorylation, but with distinct temporal patterns. STAT1 phosphorylation peaks at 15 minutes and correlates with JAK1 activation, while STAT3 phosphorylation is sustained for up to 120 minutes and appears dissociated from JAK1 activation .

• Pathway independence: Experiments with various inhibitors have revealed that IGF1R-induced STAT3 tyrosine phosphorylation is:

  • Unaffected by blockade of AT1 receptors (CV11974), endothelin-1 receptors (TAK044), or gp130 (RX435)

  • Independent of MAPK (PD98058) and PI3K (wortmannin) pathways

  • Not dependent on calcium influx (EDTA) or calmodulin kinase II (KN62)

  • Significantly attenuated by intracellular calcium chelation (BAPTA-AM) and protein kinase C inhibition (chelerythrine)

This suggests that IGF1R signaling to STAT3 in cardiomyocytes operates through calcium-dependent and PKC-dependent mechanisms that are largely independent of other major signaling pathways.

How do experimental conditions like nutrient availability affect IGF1R signaling in rats?

Nutritional status significantly influences IGF1R signaling efficacy and downstream effects in rat models. In food-deprived rats (60-72 hours of starvation), several notable changes occur:

• Baseline alterations: Compared to non-starved rats, food-deprived rats exhibit:

  • Lower single nephron glomerular filtration rate (SNGFR)

  • Reduced single nephron blood flow (SNBF) and plasma flow (SNPF)

  • A tendency toward higher afferent and efferent arteriolar resistance

  • Lower glomerular transcapillary hydrostatic pressure difference (delta P)

  • Possibly reduced ultrafiltration coefficient (LpA)

• Differential response to IGF-1: Despite these baseline differences, food-deprived rats remain responsive to IGF-1 administration. Following rhIGF-I injection and infusion, starved rats show:

  • Increased serum IGF-I levels

  • Elevated kidney GFR, SNGFR, SNBF, and SNPF

  • Decreased efferent arteriolar resistance (RE)

  • Increased ultrafiltration coefficient (LpA)

These findings suggest that while starvation alters baseline renal hemodynamics, the IGF1R signaling system remains functional and can partially counteract starvation-induced physiological changes. This highlights the importance of considering nutritional status when designing experiments to study IGF1R signaling in rat models, as baseline conditions and response magnitudes may vary considerably depending on the metabolic state of the animals.

What are the optimal protocols for detecting and quantifying IGF1R in rat samples?

Several methodologies are available for detecting and quantifying IGF1R in rat samples, each with specific applications and considerations:

• ELISA-based detection:

  • Sandwich ELISA kits provide high sensitivity (down to 0.062 ng/mL) and specificity for rat IGF1R

  • Suitable for quantification in tissue homogenates, cell lysates, and other biological fluids

  • Typical detection range: 0.156-10 ng/mL

  • Offers good reproducibility with intra-assay CV <10% and inter-assay CV <12%

• Immunoprecipitation and Western blotting:

  • Effective for detecting total and phosphorylated IGF1R

  • Allows assessment of activation status through phospho-specific antibodies

  • Requires careful optimization of lysis conditions to preserve phosphorylation status

  • Recommended primary antibodies should be validated specifically for rat IGF1R

• Immunohistochemistry/Immunofluorescence:

  • Enables visualization of IGF1R tissue distribution and cellular localization

  • Critical to include appropriate negative controls and blocking steps

  • May require antigen retrieval techniques depending on fixation methods

For optimal results, sample preparation is crucial:

• Fresh samples yield better results than frozen for phosphorylation studies

• Protease and phosphatase inhibitors must be included in all extraction buffers

• Quantification should include appropriate housekeeping controls

• Validation with positive controls (e.g., tissues known to express high IGF1R levels) is recommended

How can researchers effectively design experiments to study IGF1R signaling in rat cardiomyocytes?

Designing robust experiments to study IGF1R signaling in rat cardiomyocytes requires careful consideration of multiple factors:

• Cell isolation and culture:

  • Primary neonatal rat cardiomyocytes offer a physiologically relevant system

  • Isolation should follow established protocols using collagenase digestion

  • Culture in serum-free conditions for 24-48 hours before experiments to minimize baseline activation

  • Verification of cardiomyocyte purity (>90%) using markers like troponin T

• IGF-1 stimulation parameters:

  • Optimal concentration: 10^-8 mol/L of recombinant IGF-1 has been shown to effectively activate signaling

  • Time course considerations: Include multiple time points (2, 5, 15, 30, 60, 120 minutes) to capture both early and sustained signaling events

  • Pre-incubation period: 24-hour serum starvation is recommended

• Pathway analysis methodology:

  • JAK/STAT pathway: Assess phosphorylation of JAK1 and STAT proteins (both tyrosine and serine phosphorylation)

  • DNA binding: Use electrophoretic mobility shift assay (EMSA) with SIE (sis-inducing element) to assess functional STAT activation

  • Inhibitor studies: Include appropriate controls and inhibitors to dissect pathway dependencies:

    • BAPTA-AM (calcium chelator)

    • Chelerythrine (PKC inhibitor)

    • PD98058 (MAPK inhibitor)

    • Wortmannin (PI3K inhibitor)

    • Pathway-specific receptor blockers (CV11974, TAK044, RX435)

• Controls and validation:

  • Include vehicle-treated controls at each time point

  • Validate specificity using IGF1R-specific inhibitors or siRNA

  • Consider potential cross-talk with insulin receptor by including insulin controls

This experimental design allows for comprehensive characterization of IGF1R signaling dynamics and pathway dependencies in rat cardiomyocytes.

What methodologies are recommended for studying IGF1R effects on rat renal function?

To effectively study IGF1R effects on rat renal function, researchers should consider the following methodological approaches:

• Animal preparation and experimental design:

  • Munich Wistar rats are preferred due to surface glomeruli accessibility

  • Include both normal and experimental conditions (e.g., fed vs. starved groups)

  • Standardize hydration status and anesthesia protocols

  • Design for intravenous injection followed by continuous infusion of rhIGF-I

• Glomerular micropuncture studies:

  • This gold-standard technique allows direct assessment of single nephron function

  • Requires specialized equipment and technical expertise

  • Enables measurement of critical parameters:

    • Single nephron glomerular filtration rate (SNGFR)

    • Single nephron blood flow rate (SNBF)

    • Single nephron plasma flow rate (SNPF)

    • Glomerular capillary hydraulic pressure

    • Bowman's space pressure

    • Afferent and efferent arteriolar resistance (RA, RE)

    • Glomerular ultrafiltration coefficient (LpA)

• Whole kidney function assessment:

  • Inulin clearance for GFR measurement

  • PAH clearance for renal plasma flow

  • Plasma and urine electrolyte measurements

• Molecular analysis:

  • Tissue collection for IGF1R expression and phosphorylation analysis

  • Microdissection of nephron segments for segment-specific studies

  • Immunohistochemistry for localization of IGF1R in different renal structures

• Experimental protocol example based on established research:

  Parameter	Non-starved Control	Non-starved IGF-1	Starved Control	Starved IGF-1
  Animal preparation	Standard diet	Standard diet	60-72h food deprivation	60-72h food deprivation
  IGF-1 administration	Vehicle	1 μg/kg bolus + 0.5 μg/kg/min	Vehicle	1 μg/kg bolus + 0.5 μg/kg/min
  Duration	60 minutes	60 minutes	60 minutes	60 minutes
  Key measurements	SNGFR, SNBF, SNPF, RA, RE, LpA, delta P	SNGFR, SNBF, SNPF, RA, RE, LpA, delta P	SNGFR, SNBF, SNPF, RA, RE, LpA, delta P	SNGFR, SNBF, SNPF, RA, RE, LpA, delta P

This comprehensive approach enables detailed characterization of IGF1R effects on glomerular hemodynamics under different physiological conditions .

How should researchers interpret differences in IGF1R signaling between tissue types?

When interpreting differences in IGF1R signaling across rat tissue types, researchers should consider several key factors:

• Tissue-specific receptor expression and distribution:

  • Quantify baseline IGF1R levels across tissues using ELISA or Western blot

  • Consider receptor density, which can vary significantly between tissues

  • Evaluate the ratio of IGF1R to insulin receptor, as some effects may be mediated through hybrid receptors

  • Assess expression of IGF binding proteins (IGFBPs), which modulate IGF-1 bioavailability and receptor interaction

• Downstream signaling pathway variations:

  • Different tissues may preferentially activate distinct downstream pathways

  • In cardiomyocytes, JAK1/STAT signaling appears prominent

  • In renal tissues, effects on vascular resistance and ultrafiltration predominate

  • Variations may reflect tissue-specific expression of signaling intermediates

• Physiological context interpretation:

  • Consider the functional role of IGF1R in each tissue

  • In kidneys, effects primarily manifest as hemodynamic changes

  • In cardiomyocytes, both immediate signaling and transcriptional responses occur

  • Experimental data should be interpreted in the context of the tissue's primary functions

• Reconciling seemingly contradictory results:

  • Temporal differences in signaling may explain apparent contradictions

  • For example, STAT1 and STAT3 show different phosphorylation kinetics in cardiomyocytes

  • Carefully evaluate all experimental parameters (dose, time, animal age, preparation method)

  • Consider that parallel pathways may be activated with different thresholds or kinetics

When comparing across studies, standardization of experimental conditions is crucial, including consistent IGF-1 concentrations, treatment durations, and analytical methods.

What are common technical challenges in IGF1R research and how can they be overcome?

Researchers working with IGF1R in rat models frequently encounter several technical challenges:

• Specificity issues:

  • Challenge: IGF1R shares structural similarity with insulin receptor, leading to potential cross-reactivity

  • Solution: Use validated receptor-specific antibodies and confirm specificity with appropriate controls

  • Approach: Include competitive binding assays or receptor knockdown controls

• Phosphorylation detection difficulties:

  • Challenge: Phosphorylation status can be lost during sample processing

  • Solution: Immediate sample processing with phosphatase inhibitors is critical

  • Approach: Use fresh tissue whenever possible and maintain samples at 4°C during processing

• Variability in primary cell preparations:

  • Challenge: Inconsistent purity and viability in primary cardiomyocyte or renal cell preparations

  • Solution: Standardize isolation protocols and verify cell purity

  • Approach: Characterize each preparation using cell-specific markers before experiments

• ELISA optimization issues:

  • Challenge: Matrix effects can interfere with accurate quantification

  • Solution: Validate recovery and linearity for each sample type

  • Approach: Follow manufacturer's protocols regarding sample dilution and preparation

  Sample Type	Common Issue	Recommended Solution
  Serum/Plasma	Matrix interference	Optimize dilution (typically 1:2 to 1:5)
  Tissue Homogenates	Incomplete extraction	Use appropriate extraction buffer with protease inhibitors
  Cell Lysates	Low protein yield	Increase cell number or optimize lysis conditions
  Conditioned Media	Binding protein interference	Pre-treatment to dissociate IGF from binding proteins

• Micropuncture technical difficulties:

  • Challenge: Technically demanding procedure with potential for experimental artifacts

  • Solution: Extensive training and rigorous quality control

  • Approach: Include time-control experiments to account for preparation stability

Addressing these challenges through careful experimental design and optimization of protocols will significantly improve data quality and reproducibility in IGF1R research.

How can researchers distinguish between direct IGF1R effects and indirect effects through other signaling pathways?

Distinguishing direct IGF1R effects from indirect pathway activation is crucial for accurate interpretation of experimental results:

• Selective inhibitor approaches:

  • Use IGF1R-specific inhibitors or blocking antibodies to confirm direct receptor involvement

  • Employ downstream pathway inhibitors systematically:

    • JAK inhibitors for STAT pathway effects

    • PI3K inhibitors (wortmannin) for Akt pathway contributions

    • MEK inhibitors (PD98058) for MAPK pathway involvement

    • PKC inhibitors (chelerythrine) for PKC-dependent effects

    • Calcium chelators (BAPTA-AM) for calcium-dependent mechanisms

  • Compare inhibition patterns to identify pathway-specific effects

• Receptor modification techniques:

  • siRNA or shRNA knockdown of IGF1R

  • CRISPR-Cas9 gene editing for receptor mutations

  • Overexpression of dominant-negative receptor constructs

  • These approaches can confirm direct receptor requirements

• Time-course analysis:

  • Direct effects typically occur more rapidly than indirect effects

  • For example, JAK1 phosphorylation occurs within 2-5 minutes of IGF-1 stimulation

  • STAT1 phosphorylation peaks at 15 minutes, correlating with JAK1 activation

  • STAT3 phosphorylation is sustained for up to 120 minutes, suggesting potential secondary mechanisms

  • Design experiments with multiple time points (2, 5, 15, 30, 60, 120 minutes)

• Receptor specificity confirmation:

  • Use multiple ligands (IGF-1, IGF-2, insulin) at varying concentrations

  • Compare activation patterns and dose-response relationships

  • Utilize receptor mutants with altered binding specificity

• Downstream readout selection:

  • Choose readouts that are pathway-specific

  • For JAK/STAT pathway: SIE mobility shift in gel shift assays

  • For PI3K pathway: Akt phosphorylation

  • For MAPK pathway: ERK1/2 phosphorylation

  • Combination of readouts can help delineate pathway contributions

Through systematic application of these approaches, researchers can build a comprehensive understanding of direct IGF1R effects versus indirect signaling mechanisms in different physiological contexts.